UPDATE 1-Clariant to fight $1.4 billion ethylene claim from BASF

Reuters
14 Jan

(Adds details on other companies targeted)

BERLIN, Jan 14 (Reuters) - Clariant said it would defend itself against a claim from German rival BASF

seeking 1.4 billion euros ($1.4 billion) in damages from a group of companies, including Clariant, fined by the EU for colluding in the purchase of ethylene before 2020.

Clariant was served with a claim targeting four companies on Jan. 9, the Swiss chemicals group said in a statement issued late on Monday.

The European Commission in 2020 fined Clariant, Mexico's Orbia and U.S. group Celanese a total of 260 million euros for colluding to keep the price of ethylene purchases low, breaching European Union antitrust rules.

The EU Commission said at the time that Westlake also took part in the purchasing cartel but was spared a fine because it revealed the activities to the Commission.

Clariant said it had evidence that the conduct of the parties did not have any effect on the market.

"Clariant firmly rejects the allegation and will adamantly defend its position in the proceedings," it added.

BASF did not respond to an emailed request for comment.

A Clariant spokesperson confirmed that BASF's claims were directed at the four companies and that there would have to be a separate decision on how any compensation payment is to be distributed among them once there is a legally valid verdict.

The other companies did not immediately respond to requests for comment.

BASF's claim was filed with a Munich court, alleging damages from infringements of EU competition rules in the 2020 case, according to Clariant.

Clariant shares were down 1.5% as of 1300 GMT.

The EU Commission also said in 2020 that the four companies acknowledged their involvement in the cartel and agreed to settle the case.

($1 = 0.9747 euros)

(Writing by Rachel More and Ludwig Burger; editing by Jason Neely, Miranda Murray and Emelia Sithole-Matarise)

((rachel.more@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10